The TP53 gene, encoding for the tetrameric transcription factor p53, is the most frequently altered tumor suppressor in human cancers since the protein, through its ability to transactivate the expression of many downstream effector genes, controls several pathways whose dysregulation is highly selected in the carcinogenic process [20]. This evidence concerns the gene TP53 and neoplasm.